Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2539.2000 -5.40 (-0.21%)

NSE Sep 22, 2025 15:31 PM

25.93% Fall from 52W High

Volume: 92,964

Ajanta Pharma Ltd.

06 May 2023

2539.20

-0.21%

Ajanta Pharma (BUY): Margins appear to have bottomed out; raise to BUY

Buy: Ajanta Pharma Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Strong India and US growth in Q4 (17% YoY each) offset by declines in other businesses

Number of FII/FPI investors decreased from 385 to 371 in Jun 2025 qtr